{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:47:53Z","timestamp":1778687273462,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.taap.2013.03.010","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T10:00:36Z","timestamp":1364378436000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["In silico modeling to predict drug-induced phospholipidosis"],"prefix":"10.1016","volume":"269","author":[{"given":"Sydney S.","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Luis G.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakissa","family":"Sadrieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.03.010_bb0005","series-title":"User Manual","author":"ADMET Predictor","year":"2011"},{"key":"10.1016\/j.taap.2013.03.010_bb0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/bioinformatics\/16.5.412","article-title":"Assessing the accuracy of prediction algorithms for classification: an overview","volume":"16","author":"Baldi","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.taap.2013.03.010_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.1840120109","article-title":"Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture","volume":"12","author":"Bandyopadhyay","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2013.03.010_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"key":"10.1016\/j.taap.2013.03.010_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2013.03.010_bb0030","series-title":"Advisory Committee Meeting. Silver, Spring, MD April 14, 2010","article-title":"The regulatory challenges of phospholipidosis","author":"FDA","year":"2010"},{"key":"10.1016\/j.taap.2013.03.010_bb0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0006-2952(01)00823-1","article-title":"Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes","volume":"62","author":"Gum","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2013.03.010_bb0040","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2013.03.010_bb0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1021\/ci800038f","article-title":"Mold2, molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics","volume":"48","author":"Hong","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2013.03.010_bb0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1289\/ehp.845553","article-title":"Pulmonary and generalized lysosomal storage induced by amphiphilic drugs","volume":"55","author":"Hruban","year":"1984","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2013.03.010_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","author":"Kodavanti","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2013.03.010_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/15376510701857262","article-title":"Development of a phospholipidosis database and predictive quantitative structure\u2013activity relationship (QSAR) models","volume":"18","author":"Kruhlak","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.taap.2013.03.010_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.taap.2013.03.010_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/10408447509164014","article-title":"Drug-induced phospholipidosis","volume":"4","author":"Lullmann","year":"1975","journal-title":"CRC Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2013.03.010_bb0075","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0005-2795(75)90109-9","article-title":"Comparison of the predicted and observed secondary structure of T4 page lysozyme","volume":"405","author":"Matthews","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2013.03.010_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tiv.2008.11.010","article-title":"A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase","volume":"23","author":"Mesens","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.taap.2013.03.010_bb0090","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.tiv.2010.04.007","article-title":"Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays","volume":"24","author":"Mesens","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.taap.2013.03.010_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.taap.2013.03.010_bb0100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cmdc.201200306","article-title":"Identification of drugs inducing phospholipidosis by novel in vitro data","volume":"7","author":"Muehlbacher","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.taap.2013.03.010_bb0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.03.010_bb0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/minf.201200048","article-title":"Construction and consensus performance of (Q)SAR models for predicting phospholipidosis using a dataset of 743 compounds","volume":"31","author":"Orogo","year":"2012","journal-title":"Mol. Inf."},{"key":"10.1016\/j.taap.2013.03.010_bb0115","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.taap.2013.03.010_bb0120","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.taap.2013.03.010_bb0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.taap.2013.03.010_bb0130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"SI","key":"10.1016\/j.taap.2013.03.010_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bbalip.2008.12.007","article-title":"Endolysosomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages","volume":"6","author":"Schmitz","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2013.03.010_bb0140","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random forest: a classification and regression tool for compound classification and QSAR modeling","volume":"43","author":"Svetnik","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.taap.2013.03.010_bb0145","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.toxlet.2012.07.013","article-title":"Comparison of urinary and serum levels of di-22:6 bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats","volume":"213","author":"Thompson","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2013.03.010_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.03.010_bb0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"In silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.03.010_bb0165","series-title":"Annual Meeting of the Society of Toxicology","first-page":"126","article-title":"Computational modeling for QT prolongation: a drug cardiovascular endpoint of paramount importance","author":"Valerio","year":"2011"},{"key":"10.1016\/j.taap.2013.03.010_bb0170","series-title":"The Toxicologist","article-title":"QSAR modeling for the mutagenic potential of drug impurities with symmetry\u00ae","author":"Valerio","year":"2012"},{"key":"10.1016\/j.taap.2013.03.010_bb0175","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/jm7013953","article-title":"Assessment of drug-lipid complex formation by a high-throughput langmuir-balance and correlation to phospholipidosis","volume":"51","author":"Vitovic","year":"2008","journal-title":"J. Med. Chem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13001063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13001063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:42:20Z","timestamp":1758573740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13001063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0041008X13001063"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.03.010","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico modeling to predict drug-induced phospholipidosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}